Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Castration Sensitive Prostate Cancer

Clinical trial condition

Metastatic Castration Sensitive Prostate Cancer

Explore clinical trials studying Metastatic Castration Sensitive Prostate Cancer. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Castration Sensitive Prostate Cancer trial results

Completed

Combining Ipilimumab, Degarelix, and Radical Prostatectomy in Men With Newly Diagnosed Metastatic Castration Sensitive Prostate Cancer or Ipilimumab and Degarelix in Men With Biochemically Recurrent Castration Sensitive Prostate Cancer After Radical Prostatectomy

NCT02020070

Conditions: Metastatic Castration Sensitive Prostate Cancer
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

NCT06734130

Conditions: Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations: Moffitt Caner Center Tampa, Florida, United States

View Trial Details